Grimes & Company, Inc. Bristol Myers Squibb CO Transaction History

Grimes & Company, Inc.

  • $3.18 Billion
  • Q1 2025

A detailed history of Grimes & Company, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Grimes & Company, Inc. holds 422,774 shares of BMY stock, worth $20.4 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
422,774
Previous 436,001 3.03%
Holding current value
$20.4 Million
Previous $24.7 Million 4.56%
% of portfolio
0.81%
Previous 0.72%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 17, 2025
SELL
$53.9 - $63.11 $712,935 - $834,755
-13,227 Reduced 3.03%
422,774 $25.8 Million
Q4 2024

Jan 21, 2025
SELL
$51.92 - $59.94 $493,603 - $569,849
-9,507 Reduced 2.13%
436,001 $24.7 Million
Q3 2024

Oct 22, 2024
BUY
$39.66 - $51.75 $33,552 - $43,780
846 Added 0.19%
445,508 $23.1 Million
Q2 2024

Jul 22, 2024
BUY
$40.25 - $52.99 $2.58 Million - $3.39 Million
64,021 Added 16.82%
444,662 $18.5 Million
Q1 2024

Apr 17, 2024
BUY
$47.98 - $54.4 $1.71 Million - $1.94 Million
35,677 Added 10.34%
380,641 $20.6 Million
Q4 2023

Jan 24, 2024
BUY
$48.48 - $57.85 $655,643 - $782,363
13,524 Added 4.08%
344,964 $17.7 Million
Q3 2023

Oct 19, 2023
BUY
$57.89 - $64.73 $815,322 - $911,657
14,084 Added 4.44%
331,440 $19.2 Million
Q2 2023

Jul 19, 2023
BUY
$63.71 - $70.74 $477,251 - $529,913
7,491 Added 2.42%
317,356 $20.3 Million
Q1 2023

Apr 20, 2023
BUY
$65.71 - $74.53 $766,967 - $869,914
11,672 Added 3.91%
309,865 $21.5 Million
Q4 2022

Jan 25, 2023
BUY
$68.48 - $81.09 $186,881 - $221,294
2,729 Added 0.92%
298,193 $0
Q3 2022

Oct 28, 2022
BUY
$0.13 - $76.84 $621 - $367,141
4,778 Added 1.64%
295,464 $21 Million
Q2 2022

Jul 22, 2022
BUY
$72.62 - $79.98 $144,078 - $158,680
1,984 Added 0.69%
290,686 $22.4 Million
Q1 2022

May 06, 2022
BUY
$61.48 - $73.72 $5.78 Million - $6.93 Million
94,069 Added 48.33%
288,702 $21.1 Million
Q4 2021

Feb 01, 2022
BUY
$53.63 - $62.52 $161,158 - $187,872
3,005 Added 1.57%
194,633 $12.1 Million
Q3 2021

Nov 08, 2021
BUY
$59.17 - $69.31 $478,034 - $559,955
8,079 Added 4.4%
191,628 $11.3 Million
Q2 2021

Aug 04, 2021
BUY
$61.91 - $67.42 $236,620 - $257,679
3,822 Added 2.13%
183,549 $12.3 Million
Q1 2021

May 12, 2021
BUY
$59.34 - $66.74 $1.35 Million - $1.52 Million
22,711 Added 14.46%
179,727 $11.3 Million
Q4 2020

Feb 02, 2021
BUY
$57.74 - $65.43 $105,548 - $119,606
1,828 Added 1.18%
157,016 $9.74 Million
Q3 2020

Nov 12, 2020
SELL
$57.43 - $63.64 $259,870 - $287,971
-4,525 Reduced 2.83%
155,188 $9.36 Million
Q2 2020

Jul 31, 2020
SELL
$54.82 - $64.09 $178,932 - $209,189
-3,264 Reduced 2.0%
159,713 $9.39 Million
Q1 2020

May 05, 2020
SELL
$46.4 - $67.43 $157,760 - $229,262
-3,400 Reduced 2.04%
162,977 $9.08 Million
Q4 2019

Feb 05, 2020
SELL
$49.21 - $64.19 $403,374 - $526,165
-8,197 Reduced 4.7%
166,377 $10.7 Million
Q3 2019

Nov 05, 2019
BUY
$42.77 - $50.71 $113,810 - $134,939
2,661 Added 1.55%
174,574 $8.85 Million
Q2 2019

Jul 30, 2019
BUY
$44.62 - $49.34 $281,284 - $311,039
6,304 Added 3.81%
171,913 $7.8 Million
Q1 2019

May 02, 2019
BUY
$45.12 - $53.8 $7.12 Million - $8.49 Million
157,818 Added 2025.64%
165,609 $7.9 Million
Q4 2018

Feb 01, 2019
BUY
$48.76 - $63.23 $243 - $316
5 Added 0.06%
7,791 $405,000
Q3 2018

Nov 09, 2018
SELL
$55.19 - $62.25 $21,910 - $24,713
-397 Reduced 4.85%
7,786 $483,000
Q2 2018

Aug 10, 2018
SELL
$50.53 - $62.98 $76,856 - $95,792
-1,521 Reduced 15.67%
8,183 $453,000
Q1 2018

May 07, 2018
BUY
$59.92 - $68.98 $94,613 - $108,919
1,579 Added 19.43%
9,704 $614,000
Q4 2017

Feb 05, 2018
BUY
$59.94 - $65.35 $839 - $914
14 Added 0.17%
8,125 $498,000
Q3 2017

Nov 03, 2017
BUY
$55.23 - $63.74 $447,970 - $516,995
8,111
8,111 $517,000

Others Institutions Holding BMY

# of Institutions
2,809
Shares Held
1.59B
Call Options Held
25.9M
Put Options Held
23.9M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $103B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Grimes & Company, Inc. Portfolio

Follow Grimes & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email